Glaukos is a finished-dose manufacturer based in United States. It appears in 5 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with US FDA and EDE (AE). Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 22 April 2025 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| San Clemente, United Arab Emirates | Not on file |
| San Clemente, United States | 3012341472 |
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | 4 | 1 |
| EDE (AE) | 1 | None |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2024 | $556K | Not reported | Not reported |
Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.
Choose your molecules and target markets. Glaukos comes back tiered against every other supplier able to file there.
Start for free